Company Profile

Axonis Inc
Profile last edited on: 9/1/2021      CAGE: 8EMJ2      UEI: LR1MVZHCSJ95

Business Identifier: First-in-class therapies for currently incurable neurological disorders. Reviving neurons - restoring control
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

700 Main Street
North Cambridge, MA 02139
   (617) 863-3650
Location: Single
Congr. District: 07
County: Middlesex

Public Profile

AXONIS Therapeutics is a recent start-up structured around tackling breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders. Based in LabCentral, MA , the Axonis team is assembling a team to address adult-onset central nervous system (CNS) - disorders that - as peope are living longer - are an increasingly important need. With a focus on developing therapies in neurorestorative treatments for spinal cord injury and neuron degeneration and excitation/inhibition imbalances being an underlying problems of many debilitating neurological disorders,AXONIS is developing a pipeline of neuron-reviving therapeutics designed to enable an intrinsic ability of CNS neurons to: (1) resist neurodegeneration, (2) restore excitation/inhibition balance, and (3) regenerate.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Joanna Stanicka -- Chief Executive Officer & Founder

  Corey S Goodman -- Executive Chairman & Founder

  Shane Hegarty -- Chief Scientific Officer & Founder

  Lisa McKerracher -- Scientific Advisor & Founder

  Mark Re Pinney Chief -- Chief Financial Officer & Founder

  Jeff Stevens -- Vice President of Science and Technology

  Oswald Steward -- Scientific Advisor & Founder

  Bob Yant -- President & Founder

  Amanda Zimmerman -- Senior Scientist

Company News

There are no news available.